By using a genome-wide methylation screen, Faryna et al. found that the methylation level of NXPH1 in normal tissues was significantly higher than that in breast cancer samples, indicating it as a potential useful biomarker for tumor diagnosis (Faryna et al., 2012). Here, NXPH1 is linked to breast carcinoma.